Guidelines in Saudi Arabia and the UAE recommend the use of triple therapy of interferon IFN (IFN beta 1b: dosage of 8 MIU on alternate days for 3 doses) with ribavirin and lopinavir/ritonavir in severe and critically ill COVID-19 patients [12,13]. Here, IFNA1 is linked to COVID-19.